Cited by 128

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

MicroRNA and Target Protein Patterns Reveal Physiopathological Features of Glioma Subtypes

Lages, Elodie, Guttin, Audrey, El Atifi, Michèle, Ramus, Claire, Ipas, Hélène, Dupré, Isabelle, Rolland, Delphine, Salon, Caroline, Godfraind, Catherine, deFraipont, Florence, Dhobb, Mehdi, Pelletier, Laurent, Wion, Didier, Gay, Emmanuel, Berger, François, Issartel, Jean-Paul·2011·PLoS ONE

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0020600

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 58

  1. H Ohgaki, 2009, Genetic alterations and signaling pathways in the evolution of gliomas., Cancer Sci, 100, 2235, 10.1111/j.1349-7006.2009.01308.x · DOI · Paper page
  2. HS Phillips, 2006, Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis., Cancer Cell, 9, 157, 10.1016/j.ccr.2006.02.019 · DOI
  3. A Li, 2009, Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes., Cancer Res, 69, 2091, 10.1158/0008-5472.CAN-08-2100 · DOI
  4. S Lawler, 2009, Emerging functions of microRNAs in glioblastoma., J Neurooncol, 92, 297, 10.1007/s11060-009-9843-2 · DOI
  5. B Zhang, 2007, microRNAs as oncogenes and tumor suppressors., Dev Biol, 302, 1, 10.1016/j.ydbio.2006.08.028 · DOI
  6. M Katakowski, 2010, Functional microRNA is transferred between glioma cells., Cancer Res, 70, 8259, 10.1158/0008-5472.CAN-10-0604 · DOI
  7. H Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells., Nat Cell Biol, 9, 654, 10.1038/ncb1596 · DOI · Paper page
  8. J Balss, 2008, Analysis of the IDH1 codon 132 mutation in brain tumors., Acta Neuropathol, 116, 597, 10.1007/s00401-008-0455-2 · DOI · Paper page
  9. A Marson, 2008, Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells., Cell, 134, 521, 10.1016/j.cell.2008.07.020 · DOI
  10. A Lujambio, 2007, Genetic unmasking of an epigenetically silenced microRNA in human cancer cells., Cancer Res, 67, 1424, 10.1158/0008-5472.CAN-06-4218 · DOI
  11. Y Saito, 2006, Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells., Cancer Cell, 9, 435, 10.1016/j.ccr.2006.04.020 · DOI
  12. S Mi, 2007, MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia., Proc Natl Acad Sci USA, 104, 19971, 10.1073/pnas.0709313104 · DOI
  13. S Baskerville, 2005, Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes., RNA, 11, 241, 10.1261/rna.7240905 · DOI · Paper page
  14. QT Le, 2007, Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas., Int J Radiat Oncol Biol Phys, 69, 167, 10.1016/j.ijrobp.2007.01.071 · DOI
  15. LY Bourguignon, 2009, Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells., J Biol Chem, 284, 26533, 10.1074/jbc.M109.027466 · DOI
  16. JL Lee, 2009, Acetylation and activation of STAT3 mediated by nuclear translocation of CD44., J Cell Biol, 185, 949, 10.1083/jcb.200812060 · DOI
  17. R Diaz, 2008, Deregulated expression of miR-106a predicts survival in human colon cancer patients., Genes Chromosomes Cancer, 47, 794, 10.1002/gcc.20580 · DOI
  18. L He, 2005, A microRNA polycistron as a potential human oncogene., Nature, 435, 828, 10.1038/nature03552 · DOI
  19. G Obernosterer, 2006, Post-transcriptional regulation of microRNA expression., RNA, 12, 1161, 10.1261/rna.2322506 · DOI · Paper page
  20. C Camps, 2008, hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer., Clin Cancer Res, 14, 1340, 10.1158/1078-0432.CCR-07-1755 · DOI
  21. X Cao, 2006, Noncoding RNAs in the mammalian central nervous system., Annu Rev Neurosci, 29, 77, 10.1146/annurev.neuro.29.051605.112839 · DOI · Paper page
  22. R Fiore, 2009, Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels., Embo J, 28, 697, 10.1038/emboj.2009.10 · DOI · Paper page
  23. JY Yu, 2008, MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation., Exp Cell Res, 314, 2618, 10.1016/j.yexcr.2008.06.002 · DOI
  24. M Lagos-Quintana, 2002, Identification of tissue-specific microRNAs from mouse., Curr Biol, 12, 735, 10.1016/S0960-9822(02)00809-6 · DOI · Paper page
  25. J Silber, 2008, miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells., BMC Med, 6, 14, 10.1186/1741-7015-6-14 · DOI · Paper page
  26. EV Makeyev, 2007, The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing., Mol Cell, 27, 435, 10.1016/j.molcel.2007.07.015 · DOI · Paper page
  27. N Vo, 2005, A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis., Proc Natl Acad Sci USA, 102, 16426, 10.1073/pnas.0508448102 · DOI · Paper page
  28. T Yokota, 2009, [MicroRNA and central nervous system]., Brain Nerve, 61, 167
  29. A Kuehbacher, 2007, Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis., Circ Res, 101, 59, 10.1161/CIRCRESAHA.107.153916 · DOI
  30. J Silber, 2009, microRNAs in gliomas: small regulators of a big problem., Neuromolecular Med, 11, 208, 10.1007/s12017-009-8087-9 · DOI
  31. J Godlewski, 2010, MicroRNAs and glioblastoma; the stem cell connection., Cell Death Differ, 17, 221, 10.1038/cdd.2009.71 · DOI · Paper page
  32. JC Pang, 2009, Oncogenic role of microRNAs in brain tumors., Acta Neuropathol, 117, 599, 10.1007/s00401-009-0525-0 · DOI · Paper page
  33. JD Turner, 2010, The many roles of microRNAs in brain tumor biology., Neurosurg Focus, 28, E3, 10.3171/2009.10.FOCUS09207 · DOI
  34. Y Guan, 2010, MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance., Clin Cancer Res, 16, 4289, 10.1158/1078-0432.CCR-10-0207 · DOI
  35. L Fang, 2011, MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8., Oncogene, 30, 806, 10.1038/onc.2010.465 · DOI
  36. H Kim, 2010, Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship., Proc Natl Acad Sci USA, 107, 2183, 10.1073/pnas.0909896107 · DOI
  37. JJ Moser, 2010, The microRNA and messengerRNA profile of the RNA-induced silencing complex in human primary astrocyte and astrocytoma cells., PLoS One, 5, e13445, 10.1371/journal.pone.0013445 · DOI
  38. HC Cheung, 2009, Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines., Brain, 132, 2277, 10.1093/brain/awp153 · DOI
  39. B Malzkorn, 2009, Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas., Brain Pathol, 20, 539, 10.1111/j.1750-3639.2009.00328.x · DOI · Paper page
  40. M Inomata, 2009, MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes., Blood, 113, 396, 10.1182/blood-2008-07-163907 · DOI
  41. L Xia, 2008, miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells., Int J Cancer, 123, 372, 10.1002/ijc.23501 · DOI
  42. M Dews, 2006, Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster., Nat Genet, 38, 1060, 10.1038/ng1855 · DOI
  43. M Brock, 2009, Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway., Circ Res, 104, 1184, 10.1161/CIRCRESAHA.109.197491 · DOI
  44. KM Foshay, 2009, miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation., Dev Biol, 326, 431, 10.1016/j.ydbio.2008.11.016 · DOI
  45. A Taguchi, 2008, Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster., Cancer Res, 68, 5540, 10.1158/0008-5472.CAN-07-6460 · DOI
  46. P Birner, 2010, STAT3 tyrosine phosphorylation influences survival in glioblastoma., J Neurooncol, 100, 339, 10.1007/s11060-010-0195-8 · DOI
  47. CL Nilsson, 2010, Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells., J Proteome Res, 9, 430, 10.1021/pr9007927 · DOI
  48. F Meng, 2007, The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes., J Biol Chem, 282, 8256, 10.1074/jbc.M607712200 · DOI
  49. H Wang, 2009, Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth., Stem Cells, 27, 2393, 10.1002/stem.188 · DOI
  50. F Chen, 2010, Down-regulation of Stat3 decreases invasion activity and induces apoptosis of human glioma cells., J Mol Neurosci, 40, 353, 10.1007/s12031-009-9323-3 · DOI
  51. F Belfiore, 1995, Fatty acid synthesis from glutamate in the adipose tissue of normal subjects and obese patients: an enzyme study., Biochem Mol Med, 54, 19, 10.1006/bmme.1995.1003 · DOI
  52. J Godlewski, 2010, MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells., Mol Cell, 37, 620, 10.1016/j.molcel.2010.02.018 · DOI
  53. B Kefas, 2010, Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells., Neuro Oncol, 12, 1102, 10.1093/neuonc/noq080 · DOI
  54. SM Lee, 2009, A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress., Cell Death Differ, 16, 738, 10.1038/cdd.2009.5 · DOI
  55. LP Tan, 2009, A high throughput experimental approach to identify miRNA targets in human cells., Nucleic Acids Res, 37, e137, 10.1093/nar/gkp715 · DOI
  56. R Natté, 2005, Multiplex ligation-dependent probe amplification for the detection of 1p and 19q chromosomal loss in oligodendroglial tumors., Brain Pathol, 15, 192, 10.1111/j.1750-3639.2005.tb00520.x · DOI
  57. CL Andersen, 2004, Normalization of real-time quantitative RT-PCR data: a model based variance estimation approach to identify genes suited for normalization-applied to bladder-and colon-cancer data-sets., Cancer Research, 64, 5245, 10.1158/0008-5472.CAN-04-0496 · DOI · Paper page
  58. MW Pfaffl, 2002, Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR., Nucleic Acids Res, 30, e36, 10.1093/nar/30.9.e36 · DOI

Cited by

Sorted by citations

Metadata

Authors
Lages, E., Guttin, A., El Atifi, M., Ramus, C., Ipas, H., Dupré, I., Rolland, D., Salon, C., Godfraind, C., deFraipont, F., Dhobb, M., Pelletier, L., Wion, D., Gay, E., Berger, F., & Issartel, J.-P.
Venue
PLoS ONE
Published
2011-05-31
Volume
6
Issue
5
Pages
e20600
ISSN
1932-6203
Cited by
128
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review